Prospective cohort study of Kaposi sarcoma treated under real-world conditions in Malawi.

11569Background: Kaposi sarcoma (KS) is the leading cancer in Malawi (34% of cancers). Outside of clinical trials, prospective KS studies from sub-Saharan Africa (SSA) are few and limited by loss t...